Delcath Systems

Youtube Subscribe

Open: 7.53 Close: 7.71 Change: 0.18

The best way to get information about Delcath Systems Company Inc Stock: Use an AI.

Are looking for the most relevant information about Delcath Systems? Investor spend a lot of time searching for information to make investment decisions in Delcath Systems. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Delcath Systems are: HC, Wainwright, reiterate, system, price, target, Buy, and the most common words in the summary are: system, delcath, stock, best, inc, earnings, buy, . One of the sentences in the summary was: The average one-year price target is 16.73.73. Other searches related to …

Concept Map

Semantic Network

Stock Summary

Delcath Systems, Inc. focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. Its lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection.

Today's Summary

HC Wainwright & co. reiterates buy on delcath systems, maintains $17 price target - delcaint systems inc. (nasdaq:dcth) - benzinga. Reiterates Buy on Delcath Systems. HC Wainwright & Co. reiterated coverage of Delcath Systems ( NASDAQ:DCTH ) with a Buy recommendation on May 24, 2023. The average one-year price target is 16.73.73. The projected annual revenue for the company is 12MM, an increase of 320.80%.

Today's News

HC Wainwright & co. reiterates buy on delcath systems, maintains $17 price target - delcaint systems inc. (nasdaq:dcth) - benzinga. Reiterates Buy on Delcath Systems. HC Wainwright & Co. reiterated coverage of Delcath Systems ( NASDAQ:DCTH ) with a Buy recommendation on May 24, 2023. The average one-year price target is 16.73.73. The projected annual revenue for the company is 12MM, an increase of 320.80%.

Stock Profile

"Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with hepatic dominant ocular melanoma to investigate objective response rate in metastatic ocular melanoma. The company also provides HEPZATO as a stand-alone medical device for sale under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York."

Keywords

This document will help you to evaluate Delcath Systems without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Delcath Systems are: HC, Wainwright, reiterate, system, price, target, Buy, and the most common words in the summary are: system, delcath, stock, best, inc, earnings, buy, . One of the sentences in the summary was: The average one-year price target is 16.73.73. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #system #delcath #stock #best #inc #earnings #buy.

Read more →

Youtube Subscribe

---